NASDAQ Hosts 12th Investor Program In London In Association With Merrill Lynch Life Sciences Forum – May 12 Technology Forum - May 13

The NASDAQ Stock Market, Inc. ("NASDAQ® "; OTCBB: NDAQ), will host its 12th Investor Program, in association with Merrill Lynch, in London on May 12th and 13th 2004. Presentations will be made by the senior management of 25 companies, including 15 NASDAQ-100® companies. These presentations will be webcast live from London on Wednesday, 12th May between 0845 – 1730 (BST) and Thursday, 13th May, between 0830 – 1645 (BST).

The Program is divided into a Life Sciences Forum on Wednesday 12th May and a Technology Forum on Thursday 13th May.

Life Sciences, Pharmaceuticals and Biotechnology companies participating, in alphabetical order, are: Affymetrix Inc. (NASDAQ:AFFX); Amgen Inc. (NASDAQ:AMGN); Biomet Inc. (NASDAQ:BMET); Celgene Corp. (NASDAQ:CELG); Chiron Corp. (NASDAQ:CHIR); DENTSPLY International Inc. (NASDAQ:XRAY); Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP); Gilead Sciences Inc. (NASDAQ:GILD); Henry Schein Inc. (NASDAQ:HSIC); ImClone Systems, Inc. (NASDAQ:IMCL); INAMED Corp. (NASDAQ:IMDC); Invitrogen Corp. (NASDAQ:IVGN) and Sigma-Aldrich Corp. (NASDAQ:SIAL).

Technology companies presenting, again in alphabetical order, are: Adobe Systems Inc. (NASDAQ:ADBE); Applied Micro Circuits Corp. (NASDAQ:AMCC); Cree Inc. (NASDAQ:CREE); FileNet Corp. (NASDAQ:FILE); Flextronics International Ltd. (NASDAQ:FLEX); Garmin International Inc. (NASDAQ:GRMN); Lam Research Corp. (NASDAQ:LRCX); NVIDIA Corp. (NASDAQ:NVDA); Qlogic Corp. (NASDAQ:QLGC); Rambus Inc. (NASDAQ:RMBS); Research in Motion Ltd. (NASDAQ:RIMM) and UTStarcom Inc. (NASDAQ:UTSI).

Details of how to access the webcasts live on these dates or afterwards in archived form can be found at the NASDAQ Institutional Investor Center at investors.NASDAQ.com. The site provides the institutional investment community with access to video content and information on NASDAQ-listed companies. Since its 2003 launch, it has generated approximately 600,000 page views and over 3 million hits, with international visitors accounting for over 35% of those hits.

Richard Klein, Co-Head of US Equities in Europe for Merrill Lynch, commented, “Through its continuing involvement with the NASDAQ London program, Merrill Lynch is delighted to support such an excellent opportunity for interaction between Europe’s leading institutional investors and a high quality group of prominent US Life Sciences and Technology companies. “

Bruce Aust, Executive Vice President, NASDAQ, commented, “This is the largest investor program that we have run in London. With 26 companies presenting, we are providing institutional investors with unparalleled access to the senior management of some of the most prominent companies in the Life Science and Technology sectors. The NASDAQ Institutional Investor programs have been running successfully for over six years and are strongly supported both by our leading companies and the analyst and investment community internationally.”